OOIR: Observatory of International Research

Papers

(The median citation count of Health Economics Policy and Law is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
HEP volume 17 issue 4 Cover and Back matter	113
HEP volume 17 issue 2 Cover and Back matter	47
Including carer health-related quality of life in NICE health technology assessments in the United Kingdom	18
Special issue: On the roof top of health policy change: overlooking 21 years of the European Health Policy Group	17
Neighborhood inequalities and the decline of infant mortality in São Paulo	15
Coping with COVID-19: the role of hospital care structures and capacity expansion in five countries	12
Globalisation and mental health: is globalisation good or bad for mental health? Testing for quadratic effects	12
Financial risk protection in private health insurance: empirical evidence on catastrophic and impoverishing spending from Germany's dual insurance system	12
Exploring differences between public and private providers in primary care: findings from a large Swedish region	9
HEP volume 16 issue 3 Cover and Back matter	9
HEP volume 17 issue 3 Cover and Back matter	8
Fellow travellers in transformative times: a reflection on 21 years membership of the European Health Policy Group	6
Roadmaps to managed competition: to what extent does South Africa meet the preconditions for equity and efficiency?	6
Health misinformation and freedom of expression: considerations for policymakers	6
Private equity involvement in primary care: the case of Ireland	5
Does Medicaid expansion influence county health spending? A case of New York counties	4
Pricing of hospital services: evidence from a thematic review	4
Procedural fairness to recalibrate the power imbalance in health decision-making: comment on the report: ‘Open and inclusive: Fair processes for financing universal health coverage’	4
Reimbursement prices of new, innovative medicines in Germany: a comparison of negotiation and cost-effectiveness analysis	4
The roads to managed competition for mixed public–private health systems: a conceptual framework	3
Genomics and insurance in the United Kingdom: increasing complexity and emerging challenges	3
What is a ‘National’ ‘Health’ ‘Service’? A keyword analysis of policy documents leading to the formation of the UK NHS	3
Organising Research and Development for evidence-informed health care: some universal characteristics and a case study from the UK	2
Promoting the systematic use of real-world data and real-world evidence for digital health technologies across Europe: a consensus framework	2
Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals	2

HEP volume 17 issue 1 Cover and Front matter	2
Political determinants of health: (re) examining the role of governance in reducing maternal mortality	2
Past experiences with surprise medical bills drive issue knowledge, concern and attitudes toward federal policy intervention	2
Privatising, liberalising and dividing a welfare state without affecting universality? Debunking the myths surrounding the rapid rise of private health insurance in Sweden	2
How to fairly allocate scarce medical resources? Controversial preferences of healthcare professionals with different personal characteristics	2
Just a question of time? Explaining non-take-up of a public health insurance program designed for undocumented immigrants living in France	2
Navigating conflicting expectations in addressing healthcare scarcity: a q-methodology study on the Dutch National Health Care Institute	1
The effects of a sugar-sweetened beverage tax: moving beyond dental health outcomes and service utilisation	1
Consolidating political leadership in healthcare: a mediating institution for priority-setting as a political strategy in a local health system	1
New governance of the digital health agency: a way out of the joint decision trap to implement electronic health records in Germany?	1
Virtual reality evidence on the impact of physicians' open versus defensive communication on patients	1
Managed competition in Colombia: convergence of public and private insurance and delivery	1
HEP volume 16 issue 4 Cover and Back matter	1
From speculative to real: community attitudes towards government COVID-19 vaccine mandates in Western Australia from May 2021 to April 2022	1
How should medicines reimbursement work? The views of Spanish experts	1
HEP volume 17 issue 4 Cover and Front matter	1
HEP volume 16 issue 3 Cover and Front matter	1
Saving children's lives through interventions: a quasi-experimental analysis of GAVI	1
Medical marijuana laws and mental health in the United States	1
How reforms hamper priority-setting in health care: an interview study with local decision-makers in London	1
The impact of surprise billing laws on hospital-based physician prices and network participation	1
Response to critics of Open and Inclusive: Fair Processes for Financing Universal Health Coverage	0
A review of heath economic evaluation practice in the Netherlands: are we moving forward?	0
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment	0
Effects of public long-term care insurance on the medical service use by older people in South Korea	0
Managed competition in the United States: How well is it promoting equity and efficiency?	0
Out with the old…	0
Any lessons to learn? Pathways and impasses towards health system resilience in post-pandemic times	0
Institutional boundaries and the challenges of aligning science advice and policy dynamics: the UK and Canada in the time of COVID-19	0
Understanding household healthcare expenditure can promote health policy reform	0
Pandemic preparedness and response: a new mechanism for expanding access to essential countermeasures	0
Strengthening health system governance in Germany: looking back, planning ahead	0
Do consumers perceive and trust health insurers within a system of managed competition as prudent buyers of care?	0
Précis of Open and Inclusive: Fair Processes for Financing Universal Health Coverage	0
Australia's Response to COVID-19	0
If you were a policymaker, which treatment would you disinvest? A participatory value evaluation on public preferences for active disinvestment of health care interventions in the Netherlands	0
Accelerating integration of social needs into mainstream healthcare to achieve health equity in the COVID-19 era	0
Learning lessons about lesson-learning: Covid complexity	0
Healthcare reform in the Netherlands: after 15 years of regulated competition	0
Do patients benefit from legislation regulating step therapy?	0
HEP volume 17 issue 3 Cover and Front matter	0
Learning lessons from the COVID-19 pandemic	0
An examination of health care efficiency in Canada: a two-stage semi-parametric approach	0
Why did England change its law on deceased organ donation in 2019? The dynamic interplay between evidence and values	0
The forgotten dimension of integrated care: barriers to implementing integrated clinical care in English NHS hospitals	0
A systematic literature review of real-world evidence (RWE) on post-market assessment of medical devices	0
HEP volume 17 issue 2 Cover and Front matter	0
Publicly funded health insurance schemes and demand for health services: evidence from an Indian state using a matching estimator approach	0
Health insurance and fertility among low-income, childless, single women: evidence from the ACA Medicaid expansions	0
HEP volume 17 issue 1 Cover and Back matter	0

Successfully changing the mode of regulation in clinical priority setting: how organisational factors contributed to establishing the Norwegian priority guidelines for specialist health care services	0
Value assessment and decision-making: how to move health systems forward?	0
The normative grounds for NICE decision-making: a narrative cross-disciplinary review of empirical studies	0
Exploring the uptake of economic evaluation in Spanish reports positioning medicines for public reimbursement	0
Managed competition in Aotearoa New Zealand: past experiences and future prospects	0
Politics in all policies: how healthcare is shaped by political (in)action	0
Navigating health systems in times of inequality and uncertainty… And how we go from here	0
Strengthening primary health care in China: governance and policy challenges	0
HEP volume 16 issue 4 Cover and Front matter	0
The prevalence and consequences of support for off-label Ozempic prescriptions	0
Understanding public procurement within the health sector: a priority in a post-COVID-19 world	0
The federal government and Canada's COVID-19 responses: from ‘we're ready, we're prepared’ to ‘fires are burning’	0
Need, demand, supply in health care: working definitions, and their implications for defining access	0
Emergency care reconfiguration in the Netherlands: conflicting interests and trade-offs from a multidisciplinary perspective	0
Value-based evidence across health care sectors: a push for transparent real-world studies, data, and evidence dissemination	0
Clinical negligence cases in the English NHS: uncertainty in evidence as a driver of settlement costs and societal outcomes	0
Improving access to healthcare in Ireland: an implementation failure	0
Is the emergency department used as a substitute or a complement to primary care in Medicaid?	0
Spillover effects of financial incentives for providers onto non-targeted patients: daycase surgery in English hospitals	0
The state of American health coverage: the 2022 elections and the Affordable Care Act	0
Fair processes for financing universal health coverage?	0
Impact on the NHS and health of the UK's trade and cooperation relationship with the EU, and beyond	0
Balancing between competition and regulation in healthcare markets	0
Belgium's response to the COVID-19 pandemic	0
… and in with the new	0
Public health by organizational fix?	0
Integrated care in a Beveridge system: experiences from England and Denmark	0
Ten years of German benefit assessment: price analysis for drugs with unproven additional benefit	0
Implications of the fair processes for financing UHC report for development assistance: reflections and an application of the decision-making principles to PEPFAR	0
US public opinion about interior border checkpoints and health care access for undocumented immigrants	0
Success and failure in establishing national physician databases: a comparison between Canada and Israel	0
Preconditions for efficiency and affordability in mixed health systems: are they fulfilled in the Australian public–private mix?	0
Structuring complexity? A systemic perspective on the implementation of a disease management programme for type II diabetes care in Denmark	0
Enhancing procedural fairness: a critique of the open and inclusive approach to health financing decisions	0
Just informal patient payments are not enough, ‘personal connections’ and knowledge of the ‘rules’ are also required: a logistic regression analysis of informal practices in health care in Ukraine	0
Early child health in Africa: do ICT and democracy matter?	0
Changing roles of health insurers in France, Germany, and the Netherlands: any lessons to learn from Bismarckian systems?	0
‘Nurses are seen as general cargo, not the smart TVs you ship carefully’: the politics of nurse staffing in England, Spain, Sweden, and the Netherlands	0
Ireland's takeover of private hospitals during the COVID-19 pandemic	0
Health care reform and financial crisis in the Netherlands: consequences for the financial arena of health care organizations	0
What's the ideal World Health Organization (WHO)?	0
The inefficient effects of non-clinical factors on health care costs	0
Soft law and individual responsibility: a review of the Swedish policy response to COVID-19	0